
MT-DADMe-ImmA
CAS No. 653592-04-2
MT-DADMe-ImmA( Methylthio-DADMe-Immucillin A | MTDIA )
Catalog No. M29593 CAS No. 653592-04-2
MT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP, Ki: 90 pM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 123 | Get Quote |
![]() ![]() |
10MG | 213 | Get Quote |
![]() ![]() |
25MG | 402 | Get Quote |
![]() ![]() |
50MG | 593 | Get Quote |
![]() ![]() |
100MG | 845 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMT-DADMe-ImmA
-
NoteResearch use only, not for human use.
-
Brief DescriptionMT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP, Ki: 90 pM).
-
DescriptionMT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP, Ki: 90 pM).(In Vitro):Treatment of cultured cells with MTA and MT-DADMe-ImmA inhibit MTAP, increase cellular MTA concentrations, decrease polyamines, and induce apoptosis in FaDu and Cal27, two head and neck squamous cell carcinoma cell lines. MT-DADMe-ImmA alone does not induce apoptosis in any cell line .(In Vivo):MTAP activity slowly returns, giving a biological half-life for the action of oral MT-DADMe-ImmA of 6.3 days. The time-dependent growth of FaDu tumors in immunodeficient mice is suppressed by oral or intraperitoneal treatment with MT-DADMe-ImmA .
-
In Vitro——
-
In Vivo——
-
SynonymsMethylthio-DADMe-Immucillin A | MTDIA
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number653592-04-2
-
Formula Weight293.39
-
Molecular FormulaC13H19N5OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (340.84 mM)
-
SMILESCSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
LY195448
LY 195448 (4-(3-(2-Hydroxy-2-phenyl)ethylamino-3-methylbutyl)benzamide) is a substance present in human blood and urine that shows antitumor activity in a mouse tumor model and blocks cells in the mid-stage.
-
MCI-225
MCI-225 is a selective inhibitor of NA reuptake with 5-HT3 receptor antagonism.MCI-225 (10 mg/kg, po) showed comparable anxiolytic-like effect between single and 5-day repeated administration.?
-
Azelaprag
Azelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases.